Edition:
United Kingdom

Catalent Inc (CTLT.N)

CTLT.N on New York Stock Exchange

37.90USD
14 Nov 2018
Change (% chg)

$-0.32 (-0.84%)
Prev Close
$38.22
Open
$38.40
Day's High
$38.82
Day's Low
$37.26
Volume
322,875
Avg. Vol
251,116
52-wk High
$47.86
52-wk Low
$34.30

Chart for

About

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of... (more)

Overall

Beta: --
Market Cap(Mil.): $5,305.52
Shares Outstanding(Mil.): 125.46
Dividend: --
Yield (%): --

Financials

  CTLT.N Industry Sector
P/E (TTM): 48.96 30.86 33.64
EPS (TTM): 0.86 -- --
ROI: 3.86 14.72 14.22
ROE: 16.15 16.27 15.99

Catalent to buy Juniper Pharmaceuticals for $11.50 per share

U.S. drug contract manufacturer Catalent Inc said on Tuesday it will buy Juniper Pharmaceuticals Inc for $11.50 per share in cash.

03 Jul 2018

Catalent to buy Juniper Pharmaceuticals for $11.50 per share

July 3 U.S. drug contract manufacturer Catalent Inc said on Tuesday it will buy Juniper Pharmaceuticals Inc for $11.50 per share in cash.

03 Jul 2018

Earnings vs. Estimates